Guidelines for doctors

Updated 22 February 2018
Temabillede om medicinsk cannabis med tekst

The Danish Medicines Agency has prepared guidelines for doctors on the medicinal cannabis pilot programme (in Danish only).

Guidelines for doctors on the treatment of patients with medicinal cannabis comprised by the pilot programme

The guidelines on the medicinal cannabis pilot programme contain the Danish Medicines Agency’s professional assessment of the relevant treatment options for medicinal cannabis.

Since knowledge is insufficient in many areas, the guidelines cannot be considered to represent an actual treatment guide. The guidelines include no product-specific information on the cannabis products comprised by the pilot programme, but are based on existing knowledge about the effects and adverse reactions of THC and CBD.

The indications which the guidelines describe as relevant will appear from the doctor’s medical practice system when the doctor prescribes a cannabis product.

Product-specific information on the admitted cannabis products is available in the medical practice systems, on the website of the Danish Medicines Agency and on Medicinpriser.dk.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.